These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 20691708)

  • 1. The Leu7Pro polymorphism of the signal peptide of neuropeptide Y (NPY) gene is associated with increased levels of inflammatory markers preceding vascular complications in patients with type 2 diabetes.
    Jaakkola U; Kakko T; Seppälä H; Vainio-Jylhä E; Vahlberg T; Raitakari OT; Kallio J
    Microvasc Res; 2010 Dec; 80(3):433-9. PubMed ID: 20691708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory effects of blood leukocytes: association with vascular function in neuropeptide Y proline 7-genotyped type 2 diabetes patients.
    Kakko T; Jaakkola U; Raitakari OT; Kallio J
    Diab Vasc Dis Res; 2011 Jul; 8(3):221-8. PubMed ID: 21746772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is associated with enhanced carotid atherosclerosis in elderly patients with type 2 diabetes and control subjects.
    Niskanen L; Karvonen MK; Valve R; Koulu M; Pesonen U; Mercuri M; Rauramaa R; Töyry J; Laakso M; Uusitupa MI
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2266-9. PubMed ID: 10852461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced endothelium-dependent vasodilation in subjects with Proline7 substitution in the signal peptide of neuropeptide Y.
    Järvisalo MJ; Jartti L; Karvonen MK; Pesonen U; Koulu M; Marniemi J; Hammar N; Kaprio J; Paakkunainen U; Simell O; Raitakari OT; Rönnemaa T
    Atherosclerosis; 2003 Apr; 167(2):319-26. PubMed ID: 12818415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: the Helsinki Sudden Death Study.
    Ilveskoski E; Viiri LE; Mikkelsson J; Pörsti I; Lehtimäki T; Karhunen PJ
    Atherosclerosis; 2008 Aug; 199(2):445-50. PubMed ID: 18054939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y polymorphism increases the risk for asthma in overweight subjects; protection from atherosclerosis in asthmatic subjects--the cardiovascular risk in young Finns study.
    Jaakkola U; Kakko T; Juonala M; Lehtimäki T; Viikari J; Jääskeläinen AE; Mononen N; Kähönen M; Koskinen T; Keltikangas-Järvinen L; Raitakari O; Kallio J
    Neuropeptides; 2012 Dec; 46(6):321-8. PubMed ID: 23122776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects.
    Ukkola O; Kesäniemi YA
    Eur J Clin Nutr; 2007 Sep; 61(9):1102-5. PubMed ID: 17268419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men.
    Karvonen MK; Valkonen VP; Lakka TA; Salonen R; Koulu M; Pesonen U; Tuomainen TP; Kauhanen J; Nyyssönen K; Lakka HM; Uusitupa MI; Salonen JT
    Atherosclerosis; 2001 Nov; 159(1):145-51. PubMed ID: 11689216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the Leu7Pro polymorphism of preproNPY on diurnal NPY and hormone secretion in type 2 diabetes.
    Jaakkola U; Koulu M; Karvonen MK; Seppälä H; Pesonen U; Vahlberg T; Kallio J
    Exp Clin Endocrinol Diabetes; 2007 May; 115(5):281-6. PubMed ID: 17516289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leu7Pro polymorphism in the neuropeptide Y (NPY) gene is associated with impaired glucose tolerance and type 2 diabetes in Swedish men.
    Nordman S; Ding B; Ostenson CG; Kärvestedt L; Brismar K; Efendic S; Gu HF
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):282-7. PubMed ID: 15926114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women.
    Heikkinen AM; Niskanen LK; Salmi JA; Koulu M; Pesonen U; Uusitupa MI; Komulainen MH; Tuppurainen MT; Kröger H; Jurvelin J; Saarikoski S
    Bone; 2004 Sep; 35(3):589-94. PubMed ID: 15336593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene and changes in serum lipids during a family-based counselling intervention among school-aged children with a family history of CVD.
    Salminen M; Lehtimäki T; Fan YM; Vahlberg T; Kivelä SL
    Public Health Nutr; 2008 Nov; 11(11):1156-62. PubMed ID: 18279562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PreproNPY Pro7 protects against depression despite exposure to environmental risk factors.
    Sjöholm LK; Melas PA; Forsell Y; Lavebratt C
    J Affect Disord; 2009 Nov; 118(1-3):124-30. PubMed ID: 19264362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherosclerosis associated with dynamic inflammation changes after multifactorial intervention in short-duration type 2 diabetes: A randomized, controlled, 10-year follow-up trial.
    Shi C; Men L; Yu C; Yao J; Bai R; Yang Y; Sun L; Sun G; Song G; Zhang Y; Xing Q; Du J
    J Diabetes Complications; 2017 Aug; 31(8):1286-1292. PubMed ID: 28610945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation analysis between biochemical and biophysical markers of endothelium damage in children with diabetes type 1].
    Głowińska-Olszewska B; Urban M; Tołwińska J; Peczyńska J; Florys B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(4):221-7. PubMed ID: 16232360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus.
    Alizadeh Dehnavi R; Beishuizen ED; van de Ree MA; Le Cessie S; Huisman MV; Kluft C; Princen HM; Tamsma JT
    Eur J Intern Med; 2008 Mar; 19(2):115-21. PubMed ID: 18249307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-grade inflammation, endothelial activation and carotid intima-media thickness in type 2 diabetes.
    Leinonen ES; Hiukka A; Hurt-Camejo E; Wiklund O; Sarna SS; Mattson Hultén L; Westerbacka J; Salonen RM; Salonen JT; Taskinen MR
    J Intern Med; 2004 Aug; 256(2):119-27. PubMed ID: 15257724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and endothelial dysfunction in type 2 diabetes patients with or without microalbuminuria.
    Yu Y; Suo L; Yu H; Wang C; Tang H
    Diabetes Res Clin Pract; 2004 Aug; 65(2):95-104. PubMed ID: 15223221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation of asymmetric dimethylarginine levels to macrovascular disease and inflammation markers in type 2 diabetic patients.
    Celik M; Cerrah S; Arabul M; Akalin A
    J Diabetes Res; 2014; 2014():139215. PubMed ID: 24804267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased visceral adipose tissue mass is associated with increased C-reactive protein in patients with manifest vascular diseases.
    Faber DR; van der Graaf Y; Westerink J; Visseren FL
    Atherosclerosis; 2010 Sep; 212(1):274-80. PubMed ID: 20494358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.